Evidence map›Paper›PMID 34510289›Full record

ArticleAIDS and behavior2022

Behavioral Risk Factors for HIV Infection in Hospitalized Persons Who Co-use Stimulants and Opioids.

Raagini Jawa, Michael D Stein, Bradley Anderson, Jane M Liebschutz, Catherine Stewart, Kristina T Phillips, Joshua A Barocas

Open access · bronzeAbstract read
In one paragraph

Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Methamphetamine use and illicit opioid use during buprenorphine treatment.Journal of substance use and addiction treatment · 2023
    Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Raagini JawaSection of Infectious Diseases, Boston Medical Center, 801 Massachusetts Ave, 2nd Floor, Boston, MA, 02118, USA. Raagini.jawa@bmc.org.ORCID http://orcid.org/0000-0003-0583-7574
Michael D SteinBoston University School of Public Health, Boston, MA, USA.
Bradley AndersonBehavioral Medicine and Addictions Research, Butler Hospital, Providence, RI, USA.
Jane M LiebschutzDivision of General Internal Medicine, Center for Research On Health Care, University of Pittsburgh, Pittsburgh, PA, USA.
Catherine StewartBoston University School of Public Health, Boston, MA, USA.
Kristina T PhillipsCenter for Integrated Health Care Research, Kaiser Permanente Honolulu, Honolulu, HI, USA.
Joshua A BarocasSection of Infectious Diseases, Boston Medical Center, 801 Massachusetts Ave, 2nd Floor, Boston, MA, 02118, USA.
Boston University · USBoston Medical Center · USKaiser Permanente · USProvidence College · USUniversity of Pittsburgh · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
BU Clinical HIV/AIDS Research Training Program (BU-CHART)T32AI052074 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Benjamin P. Linas · 2003 to 2026
$6.7M
Advancing Clinical Research Training within Addiction Residency ProgramsR25DA033211 · NIDA · BOSTON MEDICAL CENTER · PI Patrick O'Connor, JEFFREY H. SAMET · 2012 to 2026
$4.2M
Preventing Bacterial and Viral Infections among Injection Drug UsersR01DA034957 · NIDA · BUTLER HOSPITAL (PROVIDENCE, RI) · PI STEIN, MICHAEL D · 2013 to 2017
$2.4M
Development of a novel community-based high-performance surveillance network for drug useDP2DA051864 · NIDA · UNIVERSITY OF COLORADO DENVER · PI BAROCAS, JOSHUA ADAM · 2020 to 2020
$2.3M
Strategies to reduce serious bacterial infections and overdose among people who inject drugsK01DA051684 · NIDA · UNIVERSITY OF COLORADO DENVER · PI BAROCAS, JOSHUA ADAM · 2020 to 2024
$809k
National Institute of Allergy and Infectious Diseases T32AI052074NIAID NIH HHS P30 AI042853NIAID NIH HHS T32 AI052074NIDA NIH HHS DP2 DA051864NIDA NIH HHS DP2DA051864-01NIDA NIH HHS K01 DA051684NIDA NIH HHS K01DA051684NIDA NIH HHS R01 DA034957NIDA NIH HHS R01DA034957NIDA NIH HHS R25 DA033211NIDA NIH HHS R25DA033211
6 · The paper itself

Abstract

We investigated the association of 90-day opioid and stimulant co-use and HIV risk behaviors in a cross-sectional analysis of hospitalized HIV-negative people who inject drugs (PWID). We compared those injecting opioids alone to two sub-groups who co-used opioids with (1) cocaine, (2) amphetamine-type stimulants (ATS), on sex and injection drug risk behaviors assessed via the Risk Assessment Battery (RAB), where a higher score indicates a higher risk. Of 197 participants who injected opioids, 53% co-used cocaine only, 5% co-used ATS only, 18% co-used both cocaine and ATS, 24% co-used neither stimulant. PWID who injected opioids alone had a mean RAB drug risk score of 5.98 points and sex risk score of 2.16 points. Compared to PWID who injected opioids alone, PWID who co-used stimulants had higher mean drug risk RAB scores: cocaine, b = 2.84 points [95% confidence interval (CI) 1.01; 4.67]; ATS, b = 3.43 points (95% CI 1.29; 5.57). Compared to PWID who injected opioids alone, cocaine co-use was associated with higher sex RAB scores b = 1.06 points (95% CI 0.32; 1.79). Overall, we found a significant association between stimulant co-use and higher HIV sex and drug risk scores.

Indexed as

HIV InfectionsSubstance Abuse, IntravenousAnalgesics, OpioidCross-Sectional StudiesHumansRisk FactorsRisk-TakingAnalgesics, OpioidHIVHIV risk behaviorsOpioid usePeople who inject drugsStimulant use

Identifiers

PMID34510289
PMCPMC8435119
OpenAlexW3201169565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.